Anteotech Ltd
AnteoTech Ltd is an Australia-based supplier of advanced material solutions to the battery materials and life sciences markets.
The business
AnteoTech Ltd is an Australia-based supplier of advanced material solutions to the battery materials and life sciences markets. Its products and technologies include Anteo X, Ultranode, AnteoBind and AnteoBind NXT. Anteo X is a water-based, binder-compatible cross linker designed to improve the mechanical stability and performance of high silicon anodes in lithium-ion batteries. Anteo X enhances cohesion between active materials, binders, and conductive agents, enabling higher silicon loadings, greater energy density, and improved cycle life. Ultranode is its proprietary high silicon anode formulation technology, developed to boost energy density in lithium-ion batteries. AnteoBind is a patented surface chemistry platform that simplifies and enhances the immobilization (bioconjugation) of biomolecules on a variety of substrates. AnteoBind NXT builds on the core AnteoBind technology, delivering improved binding efficiency, and reducing reagent usage.
Small Caps Research
No research on Anteotech Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise ADO based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
AnteoTech receives first commercial order for Ultranode silicon battery from European EV maker
Queensland-based chemistry company AnteoTech (ASX: ADO) has received a $40,000 commercial order for its proprietary Ultranode 70%-silicon battery anode technology. The maiden sale came from a European electric vehicle manufacturer (known as EV1) that has been trialling the product to assess its performance-enhancing characteristics. The ongoing trial will be carried out in parallel with EV1’s […]
AnteoTech unveils rapid and more accurate proof of concept COVID-19 test
Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multiplex test platform that can detect whether patients have been, or are currently, infected with the coronavirus. The dual […]
AnteoTech signs agreement with Merck to co-develop products for global point-of-care market
Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck KGaA to co-develop products for the world’s rapidly-growing point of care diagnostic testing market. The products will harness Merck’s full range of europium particles activated with AnteoBind to offer an advanced toolset for assay […]
AnteoTech partners with US company to develop point-of-care products using AnteoBind coatings
Chemistry and coating company AnteoTech (ASX: ADO) has signed a commercial agreement with IMRA America Inc for the joint development of AnteoBind-coated gold particles to be used in point-of-care diagnostics. Under the agreement, AnteoTech (formerly known as Anteo Diagnostics) will activate IMRA’s i-colloid gold particles with AnteoBind. The combined product will be branded and marketed […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.